Evaluation of the Efficacy and Safety of PARP Inhibitors in Advanced-Stage Epithelial Ovarian Cancer

Purpose: PARP inhibitors are a novel targeted anti-cancer drug and a large number of clinical studies on PARP inhibitors have been accomplished. This updated meta-analysis was conducted to evaluate the efficacy and safety of PARP inhibitors in advanced-stage epithelial ovarian cancer. Methods: Medli...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Oncol
Hlavní autoři: Jiang, Yifan, Zhao, Juan, Zhang, Li, Tian, Sijuan, Yang, Ting, Wang, Li, Zhao, Minyi, Yang, Qing, Wang, Yaohui, Yang, Xiaofeng
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7350528/
https://ncbi.nlm.nih.gov/pubmed/32719741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00954
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky